SBIR-STTR Award

Synthesis Of Glycosaminoglycans
Award last edited on: 1/31/14

Sponsored Program
SBIR
Awarding Agency
NIH
Total Award Amount
$299,248
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Obadiah J Plante

Company Information

Ancora Pharmaceuticals Inc

1-B Gill Street
Woburn, MA 01801
Location: Single
Congr. District: 05
County: Middlesex

Phase I

Contract Number: 261201300049C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2013
Phase I Amount
$299,248
The glycosaminoglycan (GAG) class of carbohydrates is characterized by unparalleled sequence diversity. Located on the cell surface and in the extracellular matrix, specific structural features are required for a variety of functions including coagulation, cell-signaling and wound healing among others. One limitation to elucidating detailed structure-function relationships between GAGs and their binding partners is the absence of significant quantities of chemically pure GAG oligosaccharides. The aims of this project are to: ¿ Provide an initial library oftetra-, hexa- and octasaccharide GAG sequences ¿ Develop a flexible synthetic strategy for producing multiple oligosaccharides from a single intermediate (Intermediate is defined as a chemical entity produced en route to a final product. In this case, the contractor plans to produce GAG building blocks, which shall' be modified in such a way as to generate more advanced chemical entities (intermediates), each of which can be used to produce multiple final products in the target library). ¿ Produce large quantities of GAG building blocks for use in the current proposal and in future librari

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----